HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Muh-Tsann Lai Selected Research

JNJ-26146900

1/2007A selective androgen receptor modulator that reduces prostate tumor size and prevents orchidectomy-induced bone loss in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Muh-Tsann Lai Research Topics

Disease

3Hypogonadism (Hypergonadotropic Hypogonadism)
03/2013 - 08/2007
2Wasting Syndrome (Wasting Disease)
06/2008 - 08/2007
2Osteoporosis
06/2008 - 08/2007
2Prostatic Neoplasms (Prostate Cancer)
05/2007 - 01/2007
1Neoplasms (Cancer)
01/2007
1Leiomyoma (Uterine Fibroids)
07/2006
1Endometriosis
07/2006
1Breast Neoplasms (Breast Cancer)
07/2006

Drug/Important Bio-Agent (IBA)

3Androgen Receptors (Androgen Receptor)IBA
06/2008 - 01/2007
2LigandsIBA
06/2008 - 08/2007
1Estrogens (Estrogen)FDA Link
03/2013
1JNJ 37654032IBA
06/2008
1JNJ-28330835IBA
08/2007
1Nonsteroidal Anti-AndrogensIBA
05/2007
1JNJ-26146900IBA
01/2007
1Anabolic AgentsIBA
01/2007
1Progesterone Receptors (Progesterone Receptor)IBA
07/2006
1Therapeutic UsesIBA
07/2006
1Alkaline PhosphataseIBA
07/2006
1Progestins (Progestagens)IBA
07/2006

Therapy/Procedure

1Orchiectomy (Orchidectomy)
01/2007